Masatoshi Yamazoe

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Tyrosine Kinase

Candida Albicans

Top Venues

Respirology case reports

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tatsuya Ogimoto, Hiroaki Ozasa, Takahiro Tsuji, Tomoko Yamamoto Funazo, Masatoshi Yamazoe, Kentaro Hashimoto, Hiroshi Yoshida, Kazutaka Hosoya, Hitomi Ajimizu, Takashi Nomizo, Hironori Yoshida, Masatsugu Hamaji, Toshi Menju, Akihiko Yoshizawa, Hiroshi Date, Toyohiro Hirai
Combination therapy with EGFR tyrosine kinase inhibitors and TEAD inhibitor increases tumor suppression effects in EGFR mutation-positive lung cancer. Molecular cancer therapeutics (2023)
Takahiro Tsuji, Hiroaki Ozasa, Mitsuyoshi Ueda, Shunsuke Aburaya, Tomoko Yamamoto Funazo, Koh Furugaki, Yasushi Yoshimura, Masatoshi Yamazoe, Hitomi Ajimizu, Yuto Yasuda, Takashi Nomizo, Hironori Yoshida, Yuichi Sakamori, Hiroaki Wake, Mitsuyoshi Ueda, Young Hak Kim, Toyohiro Hirai
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. Nature communications 11 (1) (2020)
Masatoshi Yamazoe, Hiromi Tomioka, Shuji Yamashita, Kazusa Egami, Kouji Oh
Mycoplasma hominis empyema following caesarean section. Respirology case reports 6 (8) (2018)